Skip to main content
Caplight Logo









UE LifeSciences

UE LifeSciences

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.uelifesciences.com/

Last Round

Grant

Aug 20, 2019

Total Funding Raised

$5.43M

Company Overview

UE LifeSciences is a medical technology company that develops non-invasive, portable diagnostic devices for early cancer detection, particularly for underserved populations.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

medical diagnostic devicepoint-of-care diagnosticsbreast cancer screeningcervical cancer screeningmedical AImedtechAI-enabled diagnosticsportable medical devicehealth technon-invasive screeningfemtechdigital healthglobal health technologytelemedicinehealth equity

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

UE LifeSciences Comparables

Compare UE LifeSciences with similar companies based on industry and business-model similarity.

UE LifeSciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bexa, Inc.
86%
Niramai Health Analytix
83%
Salva Health
81%

UE LifeSciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 20, 2019
StrategicOct 4, 2016
Series ASep 14, 2015
GrantMay 21, 2015
GrantAug 20, 2012

UE LifeSciences Investors

Notable investors and investment history

UE LifeSciences investors
InvestorRounds
The Pfizer FoundationGrant
Aarin Capital PartnersSeries A
Pennsylvania Department of HealthGrant
Capria VenturesStrategic, Series A, Grant
Bayer Cares FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 14, 2015

    $3M round led by Aarin Capital Partners

  • Aug 20, 2012

    $878K grant received from Pennsylvania Department of Health.

UE LifeSciences Filings

Explore SEC and related filing metadata, where available.

UE LifeSciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about UE LifeSciences's valuation, stock price, and market status.

Is UE LifeSciences a public or private company?

UE LifeSciences is a private company.

What is the current stock price of UE LifeSciences?

UE LifeSciences is a private company with no public stock price. No recent secondary market data is available.

How much is UE LifeSciences worth (valuation)?

Valuation information for UE LifeSciences is not publicly available.

Can I buy UE LifeSciences stock?

UE LifeSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was UE LifeSciences's last funding round?

UE LifeSciences's most recent funding round was Grant on August 20, 2019.

Who are the main investors in UE LifeSciences?

Key investors in UE LifeSciences include Aarin Capital Partners.

Will UE LifeSciences IPO soon?

No public IPO plans have been announced for UE LifeSciences.

How can I track UE LifeSciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor UE LifeSciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range66
Year Founded2009
Last FundingAug 20, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?